Article
Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Jan 2014
Kim Youngwook, Hammerman Peter S, Kim Jaegil, Yoon Ji-ae, Lee Yoomi, Sun Jong-Mu, Wilkerson Matthew D, Pedamallu Chandra Sekhar, Cibulskis Kristian, Yoo Yeong Kyung, Lawrence Michael S, Stojanov Petar, Carter Scott L, McKenna Aaron, Stewart Chip, Sivachenko Andrey Y, Oh In-Jae, Kim Hong Kwan, Choi Yong Soo, Kim Kwhanmien, Shim Young Mog, Kim Kyu-Sik, Song Sang-Yun, Na Kook-Joo, Choi Yoon-La, Hayes D Neil, Kim Jhingook, Cho Sukki, Kim Young-Chul, Ahn Jin Seok, Ahn Myung-Ju, Getz Gad, Meyerson Matthew, Park Keunchil
Abstract excerpt
PURPOSE: Lung squamous cell carcinoma (SCC) is the second most prevalent type of lung cancer. Currently, no targeted therapeutics are approved for treatment of this cancer, largely because of a lack of systematic understanding of the molecular pathogenesis of the disease. To identify therapeutic...
Topics
- Adult
- Aged
- Aged, 80 and over
- Asian People
- Carcinoma, Squamous Cell
- Class I Phosphatidylinositol 3-Kinases
- DNA-Binding Proteins
- Female
